Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Osteosarcoma × Surveys and Questionnaires × Clear all

Status

Completed 2 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 23 Neoplasms 13 Prostatic Neoplasms 11 Lung Neoplasms 7 Sarcoma 5 Colorectal Neoplasms 5 Pancreatic Neoplasms 4 Ovarian Neoplasms 4 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Stomach Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Oropharyngeal Neoplasms 3 Hematologic Neoplasms 3 Financial Stress 3 Esophageal Neoplasms 3 Signs and Symptoms 2 Papillomavirus Infections 2 Pain 2 Multiple Myeloma 2 Melanoma 2 Lymphoma 2 Head and Neck Neoplasms 2 Gastrointestinal Neoplasms 2 Endometrial Neoplasms 2 Depression 2 Chronic Pain 2 Central Nervous System Neoplasms 2 Carcinoma, Intraductal, Noninfiltrating 2 Behavior 2

Interventions

fludarabine 5 Cyclophosphamide 5 Temozolomide 4 cabozantinib 3 Zoledronic Acid 3 Gemcitabine 3 Doxorubicin 3 irinotecan sucrosofate 2 atezolizumab 2 Vincristine 2 Sunitinib 2 Specimen Handling 2 Radiosurgery 2 Methotrexate 2 Irinotecan 2 Ifosfamide 2 Disulfiram 2 Cisplatin 2 Biopsy 2 vactosertib 1 trametinib 1 talazoparib 1 surufatinib 1 silmitasertib 1 selinexor 1 regorafenib 1 penpulimab 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 pazopanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06384404 2026-03-16

UFSR for OS

Montefiore Medical Center

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡